These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20348021)

  • 1. Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes.
    Cossec JC; Marquer C; Panchal M; Lazar AN; Duyckaerts C; Potier MC
    Biochim Biophys Acta; 2010 Aug; 1801(8):839-45. PubMed ID: 20348021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
    Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
    Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-related genes in Alzheimer's disease.
    Wollmer MA
    Biochim Biophys Acta; 2010 Aug; 1801(8):762-73. PubMed ID: 20580938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of lipids in Alzheimer's disease.
    Lim WL; Martins IJ; Martins RN
    J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes.
    Marquer C; Laine J; Dauphinot L; Hanbouch L; Lemercier-Neuillet C; Pierrot N; Bossers K; Le M; Corlier F; Benstaali C; Saudou F; Thinakaran G; Cartier N; Octave JN; Duyckaerts C; Potier MC
    Mol Neurodegener; 2014 Dec; 9():60. PubMed ID: 25524049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol in Alzheimer's disease.
    Shobab LA; Hsiung GY; Feldman HH
    Lancet Neurol; 2005 Dec; 4(12):841-52. PubMed ID: 16297842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease.
    Poirier J
    Trends Mol Med; 2003 Mar; 9(3):94-101. PubMed ID: 12657430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: the cholesterol connection.
    Puglielli L; Tanzi RE; Kovacs DM
    Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders.
    Cataldo A; Rebeck GW; Ghetri B; Hulette C; Lippa C; Van Broeckhoven C; van Duijn C; Cras P; Bogdanovic N; Bird T; Peterhoff C; Nixon R
    Ann Neurol; 2001 Nov; 50(5):661-5. PubMed ID: 11706973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes.
    Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U
    Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in brain cholesterol metabolism in the APPSLxPS1mut mouse, a model for Alzheimer's disease.
    Vanmierlo T; Bloks VW; van Vark-van der Zee LC; Rutten K; Kerksiek A; Friedrichs S; Sijbrands E; Steinbusch HW; Kuipers F; Lütjohann D; Mulder M
    J Alzheimers Dis; 2010; 19(1):117-27. PubMed ID: 20061631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up.
    Nixon RA
    Am J Pathol; 2004 Mar; 164(3):757-61. PubMed ID: 14982829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cerebral cholesterol metabolism in Alzheimer disease.
    Reiss AB; Voloshyna I
    J Investig Med; 2012 Mar; 60(3):576-82. PubMed ID: 22367100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ABC transporters in the pathology of Alzheimer's disease.
    Zhao Y; Hou D; Feng X; Lin F; Luo J
    Rev Neurosci; 2017 Feb; 28(2):155-159. PubMed ID: 27997355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?
    Ledesma MD; Dotti CG
    FEBS Lett; 2006 Oct; 580(23):5525-32. PubMed ID: 16814780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin deficiency in Alzheimer's disease brains: causal or casual?
    Dotti CG; Galvan C; Ledesma MD
    Neurodegener Dis; 2004; 1(4-5):205-12. PubMed ID: 16908991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalanced cholesterol metabolism in Alzheimer's disease.
    Xue-Shan Z; Juan P; Qi W; Zhong R; Li-Hong P; Zhi-Han T; Zhi-Sheng J; Gui-Xue W; Lu-Shan L
    Clin Chim Acta; 2016 May; 456():107-114. PubMed ID: 26944571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The link between altered cholesterol metabolism and Alzheimer's disease.
    Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
    Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids as key players in Alzheimer disease: alterations in metabolism and genetics.
    Sagin FG; Sozmen EY
    Curr Alzheimer Res; 2008 Feb; 5(1):4-14. PubMed ID: 18288926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.